Nat Kellogg, CFA
President
Given the significant amount of volatility in the public markets and uncertainty surrounding the economic outlook as a result of the COVID-19 pandemic, this newsletter provides an update and outlook for private market investors.
This newsletter covers the valuation process used by private equity and debt funds, the expected impact on first quarter valuations for private market funds, how portfolios are positioned to handle the economic slowdown, what GPs are doing in this environment to protect and position their portfolio companies for the slowdown, and Marquette Associates’ outlook for the remainder of the year.
Read > What Does the COVID-19 Pandemic Mean for Private Equity Investments?
The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.
09.21.2026
For much of the past several years, the conventional view has been that higher interest rates and stretched valuations would…
09.15.2026
Over the past decade, continuation vehicles (“CV”) have become one of the fastest-growing trends in private equity. Private equity funds…
08.31.2026
Private equity has always had a few portfolio companies that refused to leave the party. Today, however, the industry appears…
08.03.2026
In the cinematic masterpiece Rocky IV, Rocky gets dazed by his opponent, Captain Ivan Drago, and complains that he sees…
07.24.2026
This video is a recording of a live webinar held July 23 by Marquette’s research team analyzing the first half…
07.22.2026
The usual midyear version of these letters has touched on year-to-date performance as well as the most influential macroeconomic and…
Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.
We respect your privacy. We will never share or sell your information.
If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.
Contact Us >